"Boiron Laboratories were searching for a quick solution to use in several of its French, as well as foreign, branches, with a regular updating of new functionalities and without technical restraint," explains Fabrice Rey, Group Treasury and Customer Management Director.

"Kyriba is very proud to be working with a group like Boiron Laboratories. Our solution meets the needs of multinational companies perfectly, accompanying them in the day-to-day management of their treasury and of their liquid assets. Furthermore, the flexibility of use and the customisation (multiple languages, multiple time zones, multiple currencies) of what we offer is a particular advantage," states Didier Martin, President of Kyriba Semea.

"Choosing Kyriba allowed use to cover flow and cash management in order to support our internal banking proposal. It has also allowed us to efficiently manage our banking communication and our customer and supplier information, to automatically count our cash operations and to carry out our third-party payments and customers' standing orders. The development of more than ten interfaces optimises the exchange with our information system. The configuration and the formation of the solution have been very effective - it took less than 2 and a half months to get from the starting point to the production stage. We have gained in productivity and in security on all our management processes. Initially the solution was to be used in France, but we plan to very quickly "connect" our international subsidiaries so that users share the same application and the same reference system, in their mother tongue; this will allow us to consolidate the group's treasury forecasts much more quickly and easily," points out Fabrice Rey.

About Boiron Laboratories:

Boiron Laboratories, a world leader in homeopathic medicine, has new development prospects following its merger with Dolisos in 2005 with an unaltered ambition: to give homeopathy a firm place within medicine. The Boiron Group currently employs nearly 4,000 people in almost 50 countries throughout the world. Among its best known drugs are: Oscillococcinum^®, Sedatif PC ^® and Homeoplasmine^®.

About Kyriba:

Kyriba is the market leader in on-demand cash management Internet application services.The very competitive price of our SaaS (Software as a Service) solution and the functional richness of our solutions give our customers control over their cash flow status, forecasted and intragroup, as well as their cash instruments.  Kyriba is a private company. Investors include GRP Partners and BRED Banque Populaire. For further information visit the Kyriba website (www.kyriba.com) or contact Kyriba on +33 1 78 94 17 90.

Kyriba Press Contact: Alexia Plathey, Kyriba, aplathey@kyriba.com : + 33 1 78 94 17 70.